SPLASH BEVERAGE GROUP, INC.

SPLASH BEVERAGE GROUP, INC. issued 767,953 shares of common stock on June 24, 2026. The shares were sold to C/M Capital Master Fund, LP, generating total gross proceeds of $117,036. This transaction was conducted under a Securities Purchase Agreement dated September 19, 2025, and was exempt from registration under Section 4(a)(2) of the Securities Act of 1933 and Rule 506(b).

Splash Beverage Group announced a CDN$300,000 strategic investment in Avicanna Inc., a commercial-stage cannabinoid-based biopharmaceutical company. This investment supports Splash's previously announced transformation into a cannabinoid-based health, wellness, and healthcare-focused platform. Splash acquired 2,000,000 common shares and 1,000,000 warrants in Avicanna, aiming to leverage Avicanna's sophisticated platform, clinical development, and healthcare system integration for the evolving medical cannabinoid market.

Splash Beverage Group announced the completion of a CDN$300,000 strategic investment in Avicanna Inc., a commercial-stage cannabinoid-based biopharmaceutical company. This move aligns with Splash's previously stated transformation into a cannabinoid-based health, wellness, and healthcare-focused platform. Splash acquired 2,000,000 common shares and 1,000,000 warrants in Avicanna, citing its sophisticated platform, intellectual property, and operational execution as key differentiators for the evolving medical cannabinoid market.

Splash Beverage Group, Inc. invested $217,479.24 in Avicanna Inc., acquiring 2,000,000 common shares and 1,000,000 warrants. This strategic investment aligns with the company's pivot towards a cannabinoid-based health and wellness platform. Concurrently, Michael Bondurant was appointed as Chief Operating Officer, bringing extensive experience in the cannabis sector. The Board also approved new employment terms and significant stock option grants for Interim CEO Brady Cobb, COO Michael Bondurant, and other key officers and directors.

Splash Beverage Group, Inc. filed an S-1 registration statement for the potential resale of up to 10,000,000 shares of common stock by C/M Capital Master Fund, LP, through an equity line of credit, from which the company may receive up to $32.16 million. The company faces significant financial distress, including recurring losses, a going concern opinion from its auditors, and a stockholders' equity deficit of ($15.3 million) as of December 31, 2025. Splash Beverage is at risk of delisting from the NYSE American due to non-compliance with listing standards, including low stockholders' equity and a declining stock price. Consequently, the company is undertaking a strategic pivot from its struggling beverage business to focus on the regulated wellness and cannabinoid markets, following the expiration of a prior acquisition letter of intent.

Splash Beverage Group, Inc. announced the sale and issuance of 3,846,332 shares of common stock between May 29 and June 1, 2026. The transaction generated total gross proceeds of $607,720. These sales were conducted under a Securities Purchase Agreement with C/M Capital Master Fund, LP, and were exempt from registration under Section 4(a)(2) of the Securities Act of 1933 and Rule 506(b).

Splash Beverage Group, Inc. provided a corporate update, announcing the submission of its NYSE American compliance plan on May 28, 2026, to address non-compliance with listing standards related to stockholders' equity. The company is awaiting a determination from NYSE American, with a potential cure period extending through January 29, 2027. Additionally, the previously announced non-binding Letter of Intent with Medterra CBD, LLC expired on May 4, 2026, and Splash is now actively evaluating new strategic opportunities and engaged in preliminary negotiations within the cannabinoid wellness sector. The company also reiterated a going concern explanatory paragraph from its 2025 Annual Report.

Splash Beverage Group provided a corporate update on its NYSE American compliance process and strategic transaction initiatives. The company submitted its compliance plan to NYSE American on May 28, 2026, following a notice of non-compliance with listing standards related to stockholders' equity, with a potential cure period extending through January 29, 2027. Additionally, the non-binding Letter of Intent with Medterra CBD, LLC expired on May 4, 2026, without a definitive agreement, though Splash is actively evaluating new strategic opportunities in the cannabinoid wellness sector and is in preliminary negotiations with multiple potential counterparties. The company also disclosed that its 2025 Annual Report included an audit opinion with an explanatory paragraph regarding its ability to continue as a going concern.

Splash Beverage Group, Inc. is transitioning its business focus from traditional beverages to the regulated wellness and cannabinoid markets, following a non-binding letter of intent to acquire Medterra CBD, LLC. Although the LOI expired, the company is actively pursuing alternative transactions in the sector. This strategic pivot comes as the company reported a net loss of $2.14 million for Q1 2026, a significant decrease in net revenues, and a worsening stockholders' deficit, alongside a going concern warning. The company also completed a 1-for-40 reverse stock split in March 2025 to maintain its NYSE American listing.

Splash Beverage Group announced the appointment of Brady Cobb as Interim Chief Executive Officer, effective May 9, 2026. Concurrently, William Meissner resigned as President, effective June 1, 2026, and will provide consulting services for six months at $5,000 per month, receiving a stock option for 250,000 shares. This leadership transition marks a strategic pivot for the company towards high-growth wellness and cannabinoid markets, while continuing to service its legacy business.